Treatment Technologies & Insights
Health-tech firm creating AI-powered apps to enhance chronic disease patient outcomes.
Founded
2016Health-tech firm creating AI-powered apps to enhance chronic disease patient outcomes.
Treatment Technologies & Insights (TTI) is a health-tech firm dedicated to enhancing the health outcomes of chronic disease patients through innovative digital solutions. Founded with a mission to transform healthcare by leveraging patient-reported outcomes (PROs) and artificial intelligence, TTI offers two primary products: chemoWave and Wave Health. These AI-powered apps are designed to assist patients in managing their health by providing personalized insights and tracking tools. TTI focuses on the chronic disease market, particularly oncology, to empower patients and healthcare providers with actionable data.
Notable achievements include a systematic review by Cedars-Sinai, which rated TTI's Wave Health as the top mobile app for tracking patient-reported outcomes in oncology. The company's ecosystem comprises an ePRO solution, a healthcare provider portal, and an AI-driven data analytics engine, which together enhance patient care and clinical decision-making. TTI's impact is evident in its ability to collect diverse real-world data, improving patient outcomes and advancing the field of digital health.
Companies similar to Treatment Technologies & Insights include Outcomes4Me, TreatmentX, Trellis Health and Caregivers Insight.
Treatment Technologies & Insights was founded in 2016.
Treatment Technologies & Insights' headquarters is located in Manhattan Beach, CA, US.
Treatment Technologies & Insights' most recent funding round was for $1.5M (USD) in August 2022.
As of Aug 31, 2022, Treatment Technologies & Insights has raised a total of $3.1M (USD).
Treatment Technologies & Insights has 18 employees as of Feb 5, 2024.
Trellis Health
